The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...

In tandem with September’s Prostate Cancer Awareness Month, Cleveland Diagnostics is kicking off a campaign to boost awareness of and education around screening tests for the disease. The flagship ...

CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a leading commercial-stage biotechnology company, is launching its inaugural Prostate Cancer Awareness Campaign this September: ‘A PSA on PSA.’ ...

Cleveland Diagnostics, a commercial-stage biotech, announced the launch of a public service announcement (PSA) this week ahead of the start of Prostate Cancer Awareness Month. Rather, Cleveland ...

What does PSA stand for? It’s short for both a “public service announcement” and an important test for men. If you’re not familiar with the second acronym, it’s time to learn more and share that ...

The Food and Drug Administration recently approved the IsoPSA blood test, which was developed by Cleveland Diagnostics, a ...

CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a pioneering precision oncology company, relaunches its third annual PSA on PSA Campaign this September for Prostate Cancer Awareness Month ...

These substantial increases highlight the growing financial burden on patients undergoing necessary diagnostic testing following an abnormal PSA test. Out-of-pocket costs (OOPCs) for diagnostic ...

Researchers identified three biomarkers that robustly detected the presence of prostate cancer Prostate biopsies after abnormal PSA blood test results are often negative and can result in unintended ...